Cite

HARVARD Citation

    Spetzler, D. et al. (n.d.). 254 Multi-platform molecular profiling of 1, 180 patients increases median overall survival and influences treatment decision in 53% of cases. European journal of cancer. pp. S44-. [Online]. 
  
Back to record